Value Hive
Value Hive

Paul Andreola: How To Find The Next XPEL

This week our guest is Paul Andreola. He is the publisher of SmallCap Discoveries and full-time microcap investor. Today, we discussed why illiquidity is a benefit, the advantages of being a CEO, his research process, immediate green and red flags, and how to spot the next $XPEL! * [0:00] Introducti

Featured Speakers

Brandon Beylo HostPaul Andriola Guest

Topics Discussed

Episode Summary

Executive Summary: Paul Andriola explains his microcap investing process: manual filing-based screening, focus on fast revenue growth and profitability, strict share-structure discipline, and opportunistic use of technicals only for timing and position management. He argues that illiquidity, market panic, and tiny niches can create exceptional mispricings, especially when combined with CEO/operator experience and patience.

Main Topics: Microcap investing under COVID and market volatility (Priority: 5/5): Andriola discusses how the pandemic changed workflow, reduced site visits and face-to-face management access, but did not fundamentally alter his process. He also highlights how panic selling in illiquid names can create buying opportunities for prepared investors. Illiquidity as an advantage in microcaps (Priority: 5/5): He frames microcap illiquidity as beneficial for buyers: forced sellers and scarce bids can create severe mispricing, enabling accumulation of high-conviction names at distressed prices. Operator experience as an investing edge (Priority: 5/5): Having been a CEO, founder, broker, and public-company operator helps him understand what is invisible in filings, appreciate management challenges, and better interpret business quality and executive behavior. Why tiny companies stay public (Priority: 4/5): He explains that many microcaps are public due to past capital-raising mistakes, pivots, and the high costs or difficulty of going private, even when market caps are far below what seems rational for public status. A Canadianized CanSlim approach (Priority: 5/5): Andriola describes adapting William O'Neil's CanSlim framework for Canadian microcaps: market-cap-based rather than price-based constraints, less reliance on institutional sponsorship, and technicals used for timing and execution rather than classic chart-pattern chasing. Manual screening and quality filters (Priority: 5/5): His process starts with manually reviewing Canadian filings (SEDAR/CDAR) for revenue growth, profitability, share structure, and ownership alignment, rather than using software screens that might miss hidden opportunities. Case studies of multibaggers from 'Cheapies with a Chance' (Priority: 4/5): He walks through examples like Senko Tech, Excelware, Inventronics, and Pawsabit to show how very small, profitable, high-growth companies with tight share structures can become large winners.

Key Arguments: Manual reading of filings is superior to software screens because it can uncover overlooked microcaps that automated tools miss. Revenue growth plus emerging profitability is the core first-pass filter; consistency matters more than a single good quarter. Balance sheets matter, but strong income statements can outweigh them because debt or financing issues can sometimes be solved by investing directly. Small, tight share structures are usually a positive sign because disciplined capital allocation often reflects disciplined business management. Technicals in microcaps are mainly about how and when to buy, not whether to buy; they help manage liquidity and entry points. The best microcap opportunities often exist in niche markets where a company can dominate a small segment and then expand into adjacent niches. Experience as an operator and CEO improves judgment because public filings reveal only a fraction of how a business actually functions. Patience is critical: the best returns come from owning cheap, growing businesses and letting execution compound over time.

Data Points: Microcap size threshold: $30M or less (later referenced as $30M–$50M range) - Approximate market-cap range Andriola says he targets in his microcap universe. Canadian public-company costs: $150,000 to $250,000 per year - Estimated bare-minimum annual cost of staying public on Canadian junior markets. Large exchange cost uplift: 10x to 20x higher - He says costs can balloon when graduating to NASDAQ or TSX. Revenue growth screen: Minimum 25% year-over-year - Initial manual screen for candidate companies. Early-profitability threshold: At least 2 quarters - He gets more confident after seeing multiple profitable quarters. Share count preference: Sub-50 million shares outstanding - He says smaller, tighter share structures tend to correlate with better outcomes. Senko Tech entry market cap: Sub-$5 million - He invested when the Canadian-listed company was extremely small. Senko Tech exit market cap: About $40 million - Approximate market cap when he exited after a strong run. Excelware starting price: 2 cents - He identified it as a very small 'Cheapies with a Chance' type opportunity. Excelware move on announcement: 2 cents to 40 cents in a day - A major revaluation after an announcement tied to novel oil-extraction technology. Inventronics share count: About 4 to 4.5 million shares outstanding - He cites a very small share count as part of the appeal. Inventronics starting price: Around 30 cents - Approximate entry price for the telecom-casing business. Pawsabit entry price: Around 17 cents - One of his sub-$10M market-cap opportunities in cannabis POS software. Pawsabit operating growth: 80% to 90% year-over-year - He says the company was growing rapidly when found. Pawsabit later price: Around $1.10 - Approximate trading level later in the cycle. BOFLEX early entry price: 80 to 90 cents - One of his first major CanSlim-style winners and an early lesson in holding winners. BOFLEX later price: Ultimately around $250 - He cites this as an example of leaving a huge amount of upside on the table. MetaFast entry price: 24 cents - A long-term example validating his process. MetaFast later price: About $160 - Approximate current/then-trading level mentioned in the transcript.

Pivotal Quotes: "fundamentals tell you what to buy, technicals tell you when to buy it" — Paul Andriola: He explains how he adapted technical analysis for microcaps, mainly as a timing and execution tool. "you got to water your flowers and cut the weeds" — Paul Andriola: He describes the importance of letting winners run and avoiding premature selling. "buy something cheap and you'd be shocked at how lucky you get" — Paul Andriola: He summarizes his core philosophy that valuation discipline creates optionality and serendipity.

Implications: For listeners, the lesson is that microcap outperformance comes from disciplined manual research, patience, and structural awareness. In illiquid markets, small advantages in timing, share structure, and conviction can produce outsized returns.

🔓 Sign Up for Unlimited Episode Search

About Value Hive

Welcome to The Hive! It's nice in here, isn't it? The Hive is a collection of investors, entrepreneurs, thinkers and individuals dedicated to getting a little smarter each day. If you're a fan of value investing, business models, eclectic success and failure stories -- this is your podcast. Our goal is to provide you the highest quality interviews with new twists on old topics. Fresh perspectives on antiquated ideas. Passionate discourse on all things investing. Join us as we strive to improve a little bit each day: https://macro-ops.com/

View all episodes from Value Hive